Nexien BioPharma Inc Sustainability Reports
The company focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals and drug delivery systems. Its clinical pathways aim to address a broad range of medical conditions and neuromuscular disorders.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300NXFNUW5RBMGY84
FIGI: BBG001SDNVN9
1 reports from 2023 to 2023
